Mercy Hospital Carthage | |
3125 Dr Russell Smith Way, Carthage, Missouri 64836 | |
(417) 358-8121 | |
Name | Mercy Hospital Carthage |
---|---|
Type | Critical Access Hospital |
Location | 3125 Dr Russell Smith Way, Carthage, Missouri |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 261338 |
NPI Number | 1265754527 |
Organization Name | NEUROLOGICAL ASSOCIATES OF THE FOUR STATES |
Doing Business As | DR. CHRISTOPHER R. ANDREW, M.D. |
Address | 3125 Dr Russell Smith Way, Carthage, MO 64836 |
Hospital Type | General Acute Care Hospital |
Phone Number | 417-359-1350 |
News Archive
"The House and Senate aren't officially back in session until later this month, but action is already well under way on merging their health-care bills," The Wall Street Journal's Washington Wire blog reports.
The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.
A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
› Verified 1 days ago
NPI Number | 1396012753 |
Organization Name | MERCY HOSPITAL CARTHAGE |
Doing Business As | MERCY MCCUNE-BROOKS HOSPITAL |
Address | 3125 Dr Russell Smith Way, Carthage, MO 64836 |
Hospital Type | General Acute Care Hospital |
Phone Number | 417-358-8121 |
News Archive
"The House and Senate aren't officially back in session until later this month, but action is already well under way on merging their health-care bills," The Wall Street Journal's Washington Wire blog reports.
The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.
A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
› Verified 1 days ago
NPI Number | 1790860575 |
Organization Name | MCCUNE-BROOKS HOSPITAL |
Doing Business As | MCCUNE-BROOKS REGIONAL HOSPITAL |
Address | 3125 Dr Russell Smith Way, Carthage, MO 64836 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 417-358-8121 |
News Archive
"The House and Senate aren't officially back in session until later this month, but action is already well under way on merging their health-care bills," The Wall Street Journal's Washington Wire blog reports.
The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.
A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
› Verified 1 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
"The House and Senate aren't officially back in session until later this month, but action is already well under way on merging their health-care bills," The Wall Street Journal's Washington Wire blog reports.
The laboratory of Dr. Fr-d-ric Charron, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered a new molecular mechanism that permits the guidance of visual nerves towards the brain.
A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than those who used longer-acting forms such as an intrauterine device (IUD) or implant.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
› Verified 1 days ago
Mercy Hospital Carthage Critical Access Hospital Location: 3125 Dr Russell Smith Way, Carthage, Missouri 64836 Phone: (417) 358-8121 |